Table 1 Clinical characteristics of 271 HCC patients according to miR-494-3p expression levels.
Feature | miR-494-3p | χ2 | p-value | |
|---|---|---|---|---|
Low (n = 135) | High (n = 136) | |||
All cases | ||||
Age, year | Â | Â | 0.089 | 0.807 |
   ≥55 | 61 | 59 |  |  |
   <55 | 74 | 77 |  |  |
Gender | Â | Â | 0.395 | 0.550 |
   Male | 120 | 124 |  |  |
   Female | 15 | 12 |  |  |
AFP, μg/L |  |  | 0.306 | 0.580 |
   Positive | 60 | 65 |  |  |
   Negative | 75 | 71 |  |  |
Cirrhosis | Â | Â | 0.089 | 0.802 |
   Present | 84 | 87 |  |  |
   Absent | 51 | 49 |  |  |
Tumor size,cm | Â | Â | 4.605 | 0.032 |
   ≥5 | 70 | 88 |  |  |
   <5 | 65 | 48 |  |  |
Tumor number | Â | Â | 4.189 | 0.041 |
   Multiple | 35 | 51 |  |  |
   Single | 100 | 85 |  |  |
Capsule | Â | Â | 1.354 | 0.273 |
   Present | 78 | 69 |  |  |
   Absent | 57 | 67 |  |  |
Vascular invasion | Â | Â | 2.016 | 0.171 |
   Present | 58 | 47 |  |  |
   Absent | 77 | 89 |  |  |
TNM stage | Â | Â | 6.777 | 0.012 |
   III–IV | 39 | 60 |  |  |
   I-II | 96 | 76 |  |  |
BCLC stage | Â | Â | 1.998 | 0.179 |
   C-D | 54 | 66 |  |  |
   A-B | 81 | 70 |  |  |